Review: in alcohol use disorders, acamprosate is more effective for inducing abstinence
while naltrexone is more effective for reducing heavy drinking and craving
Not exact matches
Nicotine users / smokers showed a significantly lower percentage of heavy - drinking days (confirmed by a blood test for heavy drinking)
while receiving
naltrexone versus placebo.
So,
while the women on placebo had lower quit rates than men, the women taking
naltrexone had quit rates similar to men.
Researcher Zagon found that low dose
naltrexone created significant inhibition of cancer cells by causing cancer cell death,
while also increasing natural killer cells and other healthy immune system defenses against cancer.
In one study, the average weight loss for a group taking a higher dose (32 mg) of
naltrexone plus bupropion for about a year was 6.1 %
while for a lower dose (16 mg) it was 5 %.